163 related articles for article (PubMed ID: 34455699)
1. Predictive significance of anti-FVIII immunoglobulin patterns on bleeding phenotype and outcomes in acquired hemophilia A: Results from the Quebec Reference Center for Inhibitors.
Bonnefoy A; Merlen C; Dubé E; Claus-Desbonnet H; Rivard GE; St-Louis J
J Thromb Haemost; 2021 Dec; 19(12):2947-2956. PubMed ID: 34455699
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of anti-factor VIII IgG ELISA in acquired hemophilia A follow-up.
Chansavang A; Philippe A; Bozinovic I; Ben Hadj Ali K; Smadja D; Helley D; Darnige L; Mauge L
Ann Hematol; 2022 Nov; 101(11):2453-2460. PubMed ID: 36125542
[TBL] [Abstract][Full Text] [Related]
3. Acquired Hemophilia A in IgG4-Related Disease: Case Report, Immunopathogenic Study, and Review of the Literature.
Sanges S; Jeanpierre E; Lopez B; Russick J; Delignat S; Carpentier B; Dubois R; Dubucquoi S; Guerrier T; Hachulla É; Hatron PY; Paris C; Susen S; Launay D; Lacroix-Desmazes S; Terriou L
Front Immunol; 2020; 11():558811. PubMed ID: 33424828
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study.
Werwitzke S; Geisen U; Nowak-Göttl U; Eichler H; Stephan B; Scholz U; Holstein K; Klamroth R; Knöbl P; Huth-Kühne A; Bomke B; Tiede A
J Thromb Haemost; 2016 May; 14(5):940-7. PubMed ID: 26988717
[TBL] [Abstract][Full Text] [Related]
5. The IgG autoimmune response in postpartum acquired hemophilia A targets mainly the A1a1 domain of FVIII.
Lapalud P; Ali T; Cayzac C; Mathieu-Dupas E; Levesque H; Pfeiffer C; Balicchi J; Gruel Y; Borg JY; Schved JF; Granier C; Lavigne-Lissalde G
J Thromb Haemost; 2012 Sep; 10(9):1814-22. PubMed ID: 22784315
[TBL] [Abstract][Full Text] [Related]
6. Comparative measurement of anti-factor VIII antibody by Bethesda assay and ELISA reveals restricted isotype profile and epitope specificity.
Towfighi F; Gharagozlou S; Sharifian RA; Kazemnejad A; Esmailzadeh K; Managhchi MR; Shokri F
Acta Haematol; 2005; 114(2):84-90. PubMed ID: 16103630
[TBL] [Abstract][Full Text] [Related]
7. Anti-factor VIII IgA as a potential marker of poor prognosis in acquired hemophilia A: results from the GTH-AH 01/2010 study.
Tiede A; Hofbauer CJ; Werwitzke S; Knöbl P; Gottstein S; Scharf RE; Heinz J; Groß J; Holstein K; Dobbelstein C; Scheiflinger F; Koch A; Reipert BM
Blood; 2016 May; 127(19):2289-97. PubMed ID: 26912467
[TBL] [Abstract][Full Text] [Related]
8. A longitudinal evaluation of anti-FVIII antibodies demonstrated IgG4 subclass is mainly correlated with high-titre inhibitor in haemophilia A patients.
Montalvão SA; Tucunduva AC; Siqueira LH; Sambo AL; Medina SS; Ozelo MC
Haemophilia; 2015 Sep; 21(5):686-92. PubMed ID: 25708525
[TBL] [Abstract][Full Text] [Related]
9. IgG subclasses of anti-FVIII antibodies during immune tolerance induction in patients with hemophilia A.
van Helden PM; van den Berg HM; Gouw SC; Kaijen PH; Zuurveld MG; Mauser-Bunschoten EP; Aalberse RC; Vidarsson G; Voorberg J
Br J Haematol; 2008 Aug; 142(4):644-52. PubMed ID: 18510679
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay.
Boylan B; Rice AS; Dunn AL; Tarantino MD; Brettler DB; Barrett JC; Miller CH; ;
J Thromb Haemost; 2015 Jan; 13(1):47-53. PubMed ID: 25354263
[TBL] [Abstract][Full Text] [Related]
11. First report of real-time monitoring of coagulation function potential and IgG subtype of anti-FVIII autoantibodies in a child with acquired hemophilia A associated with streptococcal infection and amoxicillin.
Takeyama M; Nogami K; Kajimoto T; Ogiwara K; Matsumoto T; Shima M
Int J Hematol; 2018 Jan; 107(1):112-116. PubMed ID: 28597369
[TBL] [Abstract][Full Text] [Related]
12. Cross-reacting inhibitors against recombinant porcine factor VIII in acquired hemophilia A: Data from the GTH-AH 01/2010 Study.
Türkantoz H; Königs C; Knöbl P; Klamroth R; Holstein K; Huth-Kühne A; Heinz J; Eichler H; Tiede A
J Thromb Haemost; 2020 Jan; 18(1):36-43. PubMed ID: 31448877
[TBL] [Abstract][Full Text] [Related]
13. Relapse pattern and long-term outcomes in subjects with acquired haemophilia A.
Mizrahi T; Doyon K; Dubé E; Bonnefoy A; Warner M; Cloutier S; Demers C; Castilloux JF; Rivard GE; St-Louis J
Haemophilia; 2019 Mar; 25(2):252-257. PubMed ID: 30694571
[TBL] [Abstract][Full Text] [Related]
14. Acquired hemophilia A associated with autoimmune pancreatitis with serum IgG4 elevation.
Narazaki T; Haji S; Nakashima Y; Tsukamoto Y; Tsuda M; Takamatsu A; Ohno H; Matsushima T; Matsumoto T; Nogami K; Shima M; Shiratsuchi M; Ogawa Y
Int J Hematol; 2018 Sep; 108(3):335-338. PubMed ID: 29582334
[TBL] [Abstract][Full Text] [Related]
15. The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A.
Oomen I; Verhagen M; Miranda M; Allacher P; Beckers EAM; Blijlevens NMA; van der Bom JG; Coppens M; Driessens M; Eikenboom JCJ; Fijnvandraat K; Hassan S; van Heerde WL; Hooimeijer HL; Jansen JH; Kaijen P; Leebeek FWG; Meijer D; Paul H; Rijpma SR; Rosendaal FR; Smit C; van Vulpen LFD; Voorberg J; Schols SEM; Gouw SC
Front Immunol; 2024; 15():1355813. PubMed ID: 38455035
[TBL] [Abstract][Full Text] [Related]
16. Acquired hemophilia: a case report and review of the literature.
Mulliez SM; Vantilborgh A; Devreese KM
Int J Lab Hematol; 2014 Jun; 36(3):398-407. PubMed ID: 24750687
[TBL] [Abstract][Full Text] [Related]
17. Expanding the ortholog approach for hemophilia treatment complicated by factor VIII inhibitors.
Zakas PM; Vanijcharoenkarn K; Markovitz RC; Meeks SL; Doering CB
J Thromb Haemost; 2015 Jan; 13(1):72-81. PubMed ID: 25315236
[TBL] [Abstract][Full Text] [Related]
18. Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients.
Whelan SF; Hofbauer CJ; Horling FM; Allacher P; Wolfsegger MJ; Oldenburg J; Male C; Windyga J; Tiede A; Schwarz HP; Scheiflinger F; Reipert BM
Blood; 2013 Feb; 121(6):1039-48. PubMed ID: 23243272
[TBL] [Abstract][Full Text] [Related]
19. Limit of detection and threshold for positivity of the Centers for Disease Control and Prevention assay for factor VIII inhibitors.
Miller CH; Boylan B; Shapiro AD; Lentz SR; Wicklund BM;
J Thromb Haemost; 2017 Oct; 15(10):1971-1976. PubMed ID: 28795528
[TBL] [Abstract][Full Text] [Related]
20. Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia.
Wootla B; Dasgupta S; Dimitrov JD; Bayry J; Lévesque H; Borg JY; Borel-Derlon A; Rao DN; Friboulet A; Kaveri SV; Lacroix-Desmazes S
J Immunol; 2008 Jun; 180(11):7714-20. PubMed ID: 18490775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
